Trade Summary

2 days ago, Cline Christopher R., serving as CFO at Travere Therapeutics, Inc. (TVTX), sold 2,491 shares at $46.31 per share, for a total transaction value of $115,368.00. Following this transaction, Cline Christopher R. now holds 118,658 shares of TVTX.

This sale represents a 2.00% decrease in Cline Christopher R.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 5, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 1 day after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.